• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

社论：糖尿病非酒精性脂肪性肝炎患者的无创性纤维化生物标志物。

Editorial: Noninvasive Fibrosis Biomarkers in Patients With NASH With Diabetes.

机构信息

Division of Gastroenterology and HepatologyStanford UniversityStanfordCAUSA.

VA Palo Alto Health SystemPalo AltoCAUSA.

出版信息

Hepatol Commun. 2021 Apr 9;5(4):553-555. doi: 10.1002/hep4.1662. eCollection 2021 Apr.

DOI:10.1002/hep4.1662
PMID:33860113
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8034576/
Abstract

This is an editorial about non-invasive fibrosis markers in patients with NASH and type 2 diabetes mellitus.

摘要

这是一篇关于 NASH 和 2 型糖尿病患者非侵入性纤维化标志物的社论。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/111a/8034576/5841ee124c5a/HEP4-5-553-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/111a/8034576/5841ee124c5a/HEP4-5-553-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/111a/8034576/5841ee124c5a/HEP4-5-553-g001.jpg

相似文献

1
Editorial: Noninvasive Fibrosis Biomarkers in Patients With NASH With Diabetes.社论：糖尿病非酒精性脂肪性肝炎患者的无创性纤维化生物标志物。
Hepatol Commun. 2021 Apr 9;5(4):553-555. doi: 10.1002/hep4.1662. eCollection 2021 Apr.
2
Performance of Plasma Biomarkers and Diagnostic Panels for Nonalcoholic Steatohepatitis and Advanced Fibrosis in Patients With Type 2 Diabetes.血浆生物标志物和诊断试剂盒在 2 型糖尿病患者非酒精性脂肪性肝炎和肝纤维化中的应用性能。
Diabetes Care. 2020 Feb;43(2):290-297. doi: 10.2337/dc19-1071. Epub 2019 Oct 11.
3
Association of the Non-Alcoholic Fatty Liver Disease Fibrosis Score with subclinical myocardial remodeling in patients with type 2 diabetes: A cross-sectional study in China.非酒精性脂肪性肝病纤维化评分与 2 型糖尿病患者亚临床心肌重构的相关性：中国的一项横断面研究。
J Diabetes Investig. 2021 Jun;12(6):1035-1041. doi: 10.1111/jdi.13430. Epub 2021 Jan 8.
4
Liver fibrosis markers of nonalcoholic steatohepatitis.非酒精性脂肪性肝炎的肝纤维化标志物
World J Gastroenterol. 2015 Jun 28;21(24):7427-35. doi: 10.3748/wjg.v21.i24.7427.
5
Clinical Model for NASH and Advanced Fibrosis in Adult Patients With Diabetes and NAFLD: Guidelines for Referral in NAFLD.成人糖尿病和非酒精性脂肪性肝病患者非酒精性脂肪性肝炎和晚期肝纤维化的临床模型：非酒精性脂肪性肝病转诊指南
Diabetes Care. 2015 Jul;38(7):1347-55. doi: 10.2337/dc14-1239. Epub 2015 Apr 17.
6
Relationship between three commonly used non-invasive fibrosis biomarkers and improvement in fibrosis stage in patients with non-alcoholic steatohepatitis.三种常用非侵入性纤维化生物标志物与非酒精性脂肪性肝炎患者纤维化分期改善的关系。
Liver Int. 2019 May;39(5):924-932. doi: 10.1111/liv.13974. Epub 2019 Feb 21.
7
Proteomic screening of plasma identifies potential noninvasive biomarkers associated with significant/advanced fibrosis in patients with nonalcoholic fatty liver disease.血浆蛋白质组学筛选鉴定出与非酒精性脂肪性肝病患者显著/进展性纤维化相关的潜在非侵入性生物标志物。
Biosci Rep. 2020 Jan 31;40(1). doi: 10.1042/BSR20190395.
8
Feasibility and efficiency of European guidelines for NAFLD assessment in patients with type 2 diabetes: A prospective study.欧洲2型糖尿病患者非酒精性脂肪性肝病评估指南的可行性与效率：一项前瞻性研究。
Diabetes Res Clin Pract. 2021 Jul;177:108882. doi: 10.1016/j.diabres.2021.108882. Epub 2021 Jun 1.
9
Non-invasive screening, staging and management of metabolic dysfunction-associated fatty liver disease (MAFLD) in type 2 diabetes mellitus patients: what do we know so far ?非侵入性筛查、分期和代谢相关脂肪性肝病（MAFLD）在 2 型糖尿病患者中的管理：我们目前了解多少？
Acta Gastroenterol Belg. 2022 Apr-Jun;85(2):346-357. doi: 10.51821/85.2.9775.
10
Interfering parameters in nonalcoholic fatty liver disease fibrosis score.非酒精性脂肪性肝病纤维化评分中的干扰参数。
Liver Int. 2015 Jan;35(1):285. doi: 10.1111/liv.12650. Epub 2014 Aug 21.

引用本文的文献

1
Prediction of Advanced Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease by Type IV Collagen 7S.通过IV型胶原7S预测代谢功能障碍相关脂肪性肝病中的晚期纤维化
Gastro Hep Adv. 2025 Mar 28;4(7):100668. doi: 10.1016/j.gastha.2025.100668. eCollection 2025.
2
Accuracy of type IV collagen 7S versus Enhanced Liver Fibrosis score for diagnosing fibrosis in patients with metabolic dysfunction-associated steatotic liver disease.IV型胶原7S与增强肝纤维化评分在诊断代谢功能障碍相关脂肪性肝病患者肝纤维化中的准确性
Hepatol Commun. 2024 Dec 11;9(1). doi: 10.1097/HC9.0000000000000563. eCollection 2025 Jan 1.

本文引用的文献

1
Type IV Collagen 7S Is the Most Accurate Test For Identifying Advanced Fibrosis in NAFLD With Type 2 Diabetes.IV 型胶原 7S 是识别 2 型糖尿病合并非酒精性脂肪性肝病患者中晚期纤维化的最准确检测方法。
Hepatol Commun. 2020 Nov 16;5(4):559-572. doi: 10.1002/hep4.1637. eCollection 2021 Apr.
2
Usefulness of collagen type IV in the detection of significant liver fibrosis in nonalcoholic fatty liver disease.IV 型胶原在非酒精性脂肪性肝病中检测显著肝纤维化的作用。
Ann Hepatol. 2021 Jan-Feb;20:100253. doi: 10.1016/j.aohep.2020.08.070. Epub 2020 Sep 16.
3
Enhanced liver fibrosis test for the non-invasive diagnosis of fibrosis in patients with NAFLD: A systematic review and meta-analysis.
增强型肝纤维化检测用于非酒精性脂肪性肝病患者纤维化的无创诊断：系统评价和荟萃分析。
J Hepatol. 2020 Aug;73(2):252-262. doi: 10.1016/j.jhep.2020.03.036. Epub 2020 Apr 8.
4
Performance of the PRO-C3 collagen neo-epitope biomarker in non-alcoholic fatty liver disease.PRO-C3胶原蛋白新表位生物标志物在非酒精性脂肪性肝病中的表现
JHEP Rep. 2019 Jul 4;1(3):188-198. doi: 10.1016/j.jhepr.2019.06.004. eCollection 2019 Sep.
5
The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis.全球 2 型糖尿病患者非酒精性脂肪性肝病和非酒精性脂肪性肝炎的流行病学：系统评价和荟萃分析。
J Hepatol. 2019 Oct;71(4):793-801. doi: 10.1016/j.jhep.2019.06.021. Epub 2019 Jul 4.
6
Collagen type IV remodelling gender-specifically predicts mortality in decompensated cirrhosis.IV 型胶原重塑特异性预测失代偿性肝硬化患者的死亡率。
Liver Int. 2019 May;39(5):885-893. doi: 10.1111/liv.14070. Epub 2019 Mar 7.
7
An Evaluation of the Collagen Fragments Related to Fibrogenesis and Fibrolysis in Nonalcoholic Steatohepatitis.非酒精性脂肪性肝炎中与纤维化和纤维溶解相关的胶原片段评估。
Sci Rep. 2018 Aug 17;8(1):12414. doi: 10.1038/s41598-018-30457-y.
8
Use of a metabolomic approach to non-invasively diagnose non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus.使用代谢组学方法对2型糖尿病患者的非酒精性脂肪性肝病进行无创诊断。
Diabetes Obes Metab. 2018 Jul;20(7):1702-1709. doi: 10.1111/dom.13285. Epub 2018 Apr 14.
9
Enzyme-linked immunosorbent serum assay specific for the 7S domain of Collagen Type IV (P4NP 7S): A marker related to the extracellular matrix remodeling during liver fibrogenesis.酶联免疫吸附血清测定法针对Ⅳ型胶原（P4NP 7S）的 7S 结构域：肝纤维化过程中细胞外基质重塑的相关标志物。
Hepatol Res. 2012 May;42(5):482-93. doi: 10.1111/j.1872-034X.2011.00946.x. Epub 2012 Jan 5.
10
Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma.糖尿病会增加患慢性肝病和肝细胞癌的风险。
Gastroenterology. 2004 Feb;126(2):460-8. doi: 10.1053/j.gastro.2003.10.065.